Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 1/2, Open-Label, Dose-Escalation and Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies
Sponsored by BeiGene, Ltd.
Active
$277.3K Funding
4 People
External
Related Topics
cancer,
drug development,
clinical trial,
molecular biology,
oncology
People
Lora Inclan
(CD)
Cancer Center Division
﹒Clinical Research Coordinator III
Patricia Robles Quihuis
(CD)
Cancer Center Division
﹒Research Nurse III
Michele Chu-Pilli
(CD)
Cancer Center Division
﹒Research Program Administration Officer III
Brianna Denton
(CD)
Cancer Center Division
﹒Research Compliance Manager I
